Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide.
Di Lorenzo G, Zappavigna S, Crocetto F, Giuliano M, Ribera D, Morra R, Scafuri L, Verde A, Bruzzese D, Iaccarino S, Costabile F, Onofrio L, Viggiani M, Palmieri A, De Placido P, Marretta AL, Pietroluongo E, Luce A, Abate M, Navaeiseddighi Z, Caputo VF, Celentano G, Longo N, Ferro M, Morelli F, Facchini G, Caraglia M, De Placido S, Buonerba C.
Di Lorenzo G, et al. Among authors: celentano g.
Clin Genitourin Cancer. 2021 Oct;19(5):e286-e298. doi: 10.1016/j.clgc.2021.03.021. Epub 2021 Apr 3.
Clin Genitourin Cancer. 2021.
PMID: 33958297